Clinical trial
Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease: Prospective, Controlled Medical Device Clinical Trial
NCT06113757 is registered in ClinicalTrials.gov with AVB Biotechnology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease: Prospective, Controlled Medical Device Clinical Trial
- Lead sponsor
- AVB Biotechnology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- April 15, 2024
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, covid-19 pneumonia, virus diseases